{
  "actions": [
    {
      "acted_at": "2015-07-10T10:27:00-04:00", 
      "action_code": "H32140", 
      "references": [
        {
          "reference": "CR H5078", 
          "type": "consideration"
        }
      ], 
      "text": "By unanimous consent, the Polis amendment was withdrawn.", 
      "type": "action"
    }, 
    {
      "acted_at": "2015-07-10T10:18:55-04:00", 
      "action_code": "H3A100", 
      "references": [
        {
          "reference": "CR H5077-5078", 
          "type": "consideration"
        }, 
        {
          "reference": "CR H5077", 
          "type": "text"
        }
      ], 
      "text": "Amendment (A007) offered by Mr. Polis.", 
      "type": "action"
    }, 
    {
      "acted_at": "2015-07-10", 
      "action_code": "", 
      "references": [], 
      "text": "", 
      "type": "action"
    }, 
    {
      "acted_at": "2015-07-10", 
      "action_code": "71000", 
      "references": [], 
      "text": "House amendment offered", 
      "type": "action"
    }, 
    {
      "acted_at": "2015-07-10T10:18:55-04:00", 
      "action_code": "71500", 
      "references": [
        {
          "reference": "CR H5077-5078", 
          "type": "consideration"
        }, 
        {
          "reference": "CR H5077", 
          "type": "text"
        }
      ], 
      "text": "House amendment offered/reported by : Amendment (A007) offered by Mr. Polis.", 
      "type": "action"
    }
  ], 
  "amendment_id": "hamdt662-114", 
  "amendment_type": "hamdt", 
  "amends_amendment": null, 
  "amends_bill": {
    "bill_id": "hr6-114", 
    "bill_type": "hr", 
    "congress": 114, 
    "number": 6
  }, 
  "amends_treaty": null, 
  "chamber": "h", 
  "congress": "114", 
  "description": "Page 235, insert after line 2 the following new subtitle:    Subtitle R--Other Provisions    SEC. 2321. STUDY ON TWO-TIERED APPROVAL PROCESS FOR DEVICES BY FDA.***.", 
  "introduced_at": "2015-07-10", 
  "number": 662, 
  "purpose": "An amendment numbered 7 printed in House Report 114-193 to direct the Food and Drug Administration to issue a report on the risks and benefits associated with a two-tiered approval process that would permit certain medical devices to provisionally come to market if they have demonstrated safety but not efficacy.", 
  "sponsor": {
    "bioguide_id": "P000598", 
    "district": "2", 
    "name": "Polis, Jared", 
    "state": "CO", 
    "thomas_id": "01910", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "offered", 
  "status_at": "2015-07-10", 
  "updated_at": "2016-08-01T13:26:00Z"
}